(MENAFN- GlobeNewsWire - Nasdaq)
Seoul, South Korea, July 29, 2022 (GLOBE NEWSWIRE) -- As per industry analysis by Fact.MR, a market research and competitive intelligence provider, the global spinal surgery products market is projected to expand at a CAGR of 4.3% and reach a market value of US$ 15.5 billion by the end of 2030.
The market is divided into degenerative disc disease, traumas & fractures, complicated deformities, and others based on disease indication. Due to the rising number of disc replacement procedures and the increased demand for artificial discs, degenerative disc disease is predicted to hold the largest share of the market in 2022. One of the most common problems in the world today is lower back pain, which is predicted to favour the growth of the degenerative disc disease market.
For Critical Insights on Spinal Surgery Products Market, Request a Sample Report
Increase in the number of births with abnormalities causing modification or misalignment in the spinal column and rising elderly population are predicted to drive the complicated deformity sector. The traumas & fractures market is expected to grow significantly between 2022 and 2030 due to the rise in spinal injuries and fractures, attractive reimbursement scenario, and the need for less invasive procedures.
Which Regions Should Spinal Surgery Product Manufacturers Focus On?
“Presence of Key Market Players & High Prevalence of Chronic Illnesses Driving Sales of Spinal Surgery Equipment in North America & Europe”
The market is anticipated to be dominated by North America throughout the forecast period. The reasons for North America's dominance in the global market are new product releases, strategic alliances, increasing biologics research, and an increase in the prevalence of spinal illnesses.
The main factors driving market expansion in Europe include favourable health reimbursement, strong demand for medical equipment in Germany and the U.K., and rising rates of spine surgery. It is anticipated that government funding and active investment will dominate the Europe market.
Due to the rising geriatric population, increasing prevalence of degenerative illnesses, and lower back discomfort, the demand for orthopedic spine devices in the Asia Pacific region is anticipated to soar during the projected period.
One of the main factors boosting the spine surgery products market in Latin America, the Middle East, and Africa is the expansion of prominent manufacturers' distribution networks in emerging countries and rising healthcare spending.
To learn more about Spinal Surgery Products Market, you can get in touch with our Analyst at
Key Segments Covered in the Spinal Surgery Products Industry Survey
- B y Device :
- Fusion Devices
- Non-fusion Devices
- Others
- B y Disease Indication :
- Degenerative Disc Disease
- Complex Deformity
- Traumas & Fractures
- Others
- B y End Use :
- Hospitals
- Ambulatory Surgery Centers
- Specialty Clinics
- Others
- B y Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Competitive Landscape
Key players are engaging in a variety of strategic measures to increase their market shares, including mergers and acquisitions, technology partnerships, collaborations, and the creation and introduction of cutting-edge products.
- Cohere TLIF-O implant and Cohere TLIF-A implant for posterior spine surgery were both introduced by NuVasive in October 2021.
- Stryker declared a definitive merger agreement in January 2022, under which, it would pay US$ 79.25 per share, or a total equity value of roughly US$ 2.97 billion, and a total estimated value of roughly US$ 3.09 billion, to procure all the issued and outstanding shares of common stock of Vocera Communications, Inc.
Get Customization on Spinal Surgery Products Market Report for Specific Research Solutions
Key players in the Spinal Surgery Products Market
- Zimmer Biomet
- Stryker Corporation
- Depuy Synthes
- Medtronic
- Globus Medical Inc.
- RTI Surgical Holdings
- Ulrich GmbH & Co. KG
- B. Braun Melsungen AG
- Seaspine Holdings Corporation
Key Takeaways from Spinal Surgery Products Market Study
- The global spinal surgery products market is set to reach a valuation of US$ 15.5 billion by 2030.
- Demand for spinal surgery products is expected to rise at a CAGR of 4.3% from 2022 to 2030.
- Due to the rising number of Americans experiencing lower back pain and other ailments related to the spine each year, the United States currently holds a dominant position in the North America market for spinal surgery devices.
- As more spinal fusion procedures are performed, spinal fusion equipment is expected to hold the highest market share in 2022. High growth has been brought on by technological advancements in spine fusion surgeries, whether internal fixation is used or not.
Fact.MR's Domain Expertise in Healthcare Sector
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Explore Fact.MR's Coverage on the Healthcare Domain-
Gene Therapy Market - The global gene therapy market is slated to acquire a valuation of US$ 1.85 Billion in 2022, up from US$ 1.55 Billion in 2021, representing a Y-o-Y increase of 19.3%. From 2022-2032, the market is poised to register a CAGR of 18.5%, reaching a valuation of US$ 10.1 Billion.
Diagnostic Imaging Services Market - Demand for diagnostic imaging services reached a valuation of US$ 555 Million in 2021, and is projected to reach US$ 585 Million in 2022, exhibiting a Y-o-Y growth rate of 5.4%. From 2022 to 2032, the industry is poised to grow at a CAGR of 5.51% to reach a valuation of US$ 1 Billion.
Drug Delivery Systems Market - The worldwide drug delivery systems market was worth around US$ 40 Billion in 2022 and is expected to grow at a CAGR of more than 7.8% from 2022 to 2032, reaching roughly US$ 80 Billion by 2032.
Medical Waste Management Market - The global medical waste management market, which projects market growth at a CAGR of 6.2% from 2021 to 2028. Revenue from medical waste management services accounted for US$ 15.3 Bn in 2020, and is estimated to surge to US$ 25.2 Bn by the end of 2028.
Heart Attack Diagnostics Market - The heart attack diagnostics market is predicted to grow at a moderate CAGR of 7.1% during the forecast period of 2022 to 2032. The global heart attack diagnostics market is estimated to reach a value of nearly US$ 22.2 Billion by 2032 by growing from US$ 10.4 Billion in 2021.
Drug Discovery Services Market - The drug discovery services market is forecasted to reach US$ 50 Billion by 2032, up from US$ 19 Billion in 2022, at a CAGR of 10.1%. A Y-o-Y growth rate of nearly 12% is expected for the market in 2022. As of 2021, the market was valued at US$ 17 Billion.
Lab Automation Market - Demand for lab automation services experienced a Y-o-Y expansion rate of over 11% in 2022 compared to 2021, rising from US$ 1.8 Billion to US$ 2 Billion. Going forward, the market is poised to flourish at a 7% value CAGR from 2022-2032, reaching a valuation of nearly US$ 4 Billion.
Patient Engagement Solutions Market - The global patient engagement solutions market, the market is gaining traction steadily, rising at an 8.6% CAGR through 2032, exceeding a valuation of around US$ 29 Billion by 2022. As of the end of 2032, the market is expected to reach US$ 66.4 Billion.
Smart Implants Market - The global smart implants market is estimated at US$ 3.9 billion in 2022, and is forecast to surpass a market value of US$ 22.2 billion by 2032. Smart implants are expected to contribute significantly to the global implants market, with demand surging at a CAGR of 19% from 2022 to 2032.
Facial Implants Market - The global facial implant market was valued at US$ 2.7 Billion in 2022, and is expected to rise at a 7.7% value CAGR, likely to reach US$ 5.6 Billion by the end of the 2022-2032 forecast period.
About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email:
Tel: +1 (628) 251-1583
Follow Us: LinkedIn | Twitter
Tags Spinal Surgery Products Market Spinal Fusion Devices Non-fusion Spinal Devices Degenerative Disc Disease Related Links
- Biomarkers Market Analysis by Disease Type (Cardiovascular Diseases, Cancer, Neurological Diseases, Immunological Diseases), by Type (Safety, Efficacy, Validation Biomarkers), by Application & by Region - Global Forecast 2022-2032
- Dental Services Market Analysis Report By Service Type (Dental Implants, Orthodontics, Periodontics, Endodontics, Cosmetic Dentistry, Laser Dentistry, Dentures), By End-Use (Hospitals, Dental Clinics), By Region - Global Insights 2022-2032
- Endoscopy Devices Market Analysis By Device Type (Endoscopes, Endoscopy Visualization Systems, Operative Devices), By Application (Gastrointestinal (GI) endoscopy, Arthroscopy, Laparoscopy, Bronchoscopy), By End-Use & Region - Global Forecast 2022-2032
- Endodontic Devices Market Analysis by Type (Instruments [Apex Locators, Endodontic Motors, Endodontic Scalers, Endodontic Lasers], Endodontic Consumables [Access Preparation, Shaping and Cleaning, Obturation], by End User, by Region - Global Forecast 2032
- Glioblastoma Multiforme Treatment Market Analysis by Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy), by Drug Class (Temozolomide, Bevacizumab, Carmustine Wafers), by Application, by Region - Global Forecast 2022-2032
MENAFN28072022004107003653ID1104610461